Vigabatrin Hydrochloride
≥99%
- Product Code: 103209
CAS:
1391054-02-6
| Molecular Weight: | 165.62 g./mol | Molecular Formula: | C₆H₁₂ClNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Vigabatrin Hydrochloride is primarily used in the treatment of epilepsy, specifically for managing refractory complex partial seizures in adults and as a therapy for infantile spasms in children. It works by inhibiting the breakdown of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain, thereby increasing GABA levels and reducing seizure activity. This medication is often prescribed when other antiepileptic drugs have failed to control seizures effectively. Due to its potential to cause vision loss, its use is closely monitored, and regular ophthalmologic evaluations are required during treatment. It is administered orally and is available in tablet or powder form for solution.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 99 |
| 1 H Nmr Spectrum | Consistent With Structure |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $186.02 |
+
-
|
Vigabatrin Hydrochloride
Vigabatrin Hydrochloride is primarily used in the treatment of epilepsy, specifically for managing refractory complex partial seizures in adults and as a therapy for infantile spasms in children. It works by inhibiting the breakdown of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain, thereby increasing GABA levels and reducing seizure activity. This medication is often prescribed when other antiepileptic drugs have failed to control seizures effectively. Due to its potential to cause vision loss, its use is closely monitored, and regular ophthalmologic evaluations are required during treatment. It is administered orally and is available in tablet or powder form for solution.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :